You are viewing a javascript disabled version of the site. Please enable Javascript for this site to function properly.
Go to headerGo to navigationGo to searchGo to contentsGo to footer
In content section. Select this link to jump to navigation

Author Index Volume 4 (2015)

The issue number is given in front of the pagination

Adams, W.H., see Beglinger, L.J. (3) 251-260

Alikhan, F.S., see Wegrzynowicz, M. (1) 17-36

Allen, N.D., see Mort, M. (2) 161-171

Armesto, D., see Cubo, E. (1) 75-85

Arning, L., C.N. Witt, J.T. Epplen and S. Stemmler, Genetic Counselling for Predictive Testing in Huntington’s Disease in One Centre since 1993. Gender-Specific Aspects of Decision-Making (1) 87-98

Aronin, N., see Johnson, E. (3) 219-229

Aronin, N., see Vodicka, P. (2) 187-201

Barker, R.A., see Mason, S. (1) 49-59

Barker, R.A., see Tedroff, J. (2) 131-140

Beglinger, L.J., W.H. Adams, J.G. Fiedorowicz, K. Duff, D. Langbehn, K. Biglan, J. Caviness, B. Olson and J.S. Paulsen, Practice Effects and Stability of Neuropsychological and UHDRS Tests Over Short Retest Intervals in Huntington Disease (3) 251-260

Bichell, T.J., see Wegrzynowicz, M. (1) 17-36

Biglan, K., see Beglinger, L.J. (3) 251-260

Bijlsma, E.K., see Oosterloo, M. (2) 141-148

Björkqvist, M., see McCourt, A.C. (4) 371-382

Bohlen, S., see Reilmann, R. (1) 37-47

Bowman, A.B., see Wegrzynowicz, M. (1) 17-36

Brooks, S.P., see Steventon, J.J. (2) 149-160

Camara, R.J., see Cubo, E. (1) 75-85

Carlisle, F.A., see Mort, M. (2) 161-171

Caviness, J., see Beglinger, L.J. (3) 251-260

Chase, K., see Johnson, E. (3) 219-229

Chua, P., see Poudel, G.R. (4) 325-332

Churchyard, A., see Poudel, G.R. (4) 325-332

Churchyard, A., see Vaportzis, E. (2) 119-130

Cole, J.H., see Gregory, S. (4) 333-346

Cornejo-Herrera, I.F., see Cornejo-Olivas, M.R. (1) 99-105

Cornejo-Olivas, M.R., M.A. Inca-Martinez, K. Espinoza-Huertas, D. Veliz-Otani, M.R. Velit-Salazar, V. Marca, O. Ortega, I.F. Cornejo-Herrera, S. Lindo-Samanamud, P. Mora-Alferez and P. Mazzetti, Clinical and Molecular Features of Late Onset Huntington Disease in a Peruvian Cohort (1) 99-105

Correia, K., D. Harold, K.-H. Kim, P. Holmans, L. Jones, M. Orth, R.H. Myers, S. Kwak, V.C. Wheeler, M.E. MacDonald, J.F. Gusella and J.-M. Lee, The Genetic Modifiers of Motor Onset Age (GeM MOA) Website: Genome-wide Association Analysis for Genetic Modifiers of Huntington’s Disease (3) 279-284

Coughlin, J.M., see Wegrzynowicz, M. (1) 17-36

Crane, K., see Tereshchenko, A. (3) 231-238

Craufurd, D., see Gregory, S. (3) 239-249

Craufurd, D., see McNally, G. (4) 347-369

Cubo, E., J. Rivadeneyra, D. Armesto, N. Mariscal, A. Martinez, R.J. Camara and on behalf of the Spanish members of the European Huntington Disease Network, Relationship between Nutritional Status and the Severity of Huntington’s Disease. A Spanish Multicenter Dietary Intake Study (1) 75-85

D’Cruz, G., see Smith, S. (3) 261-270

Dawson, J., see Tereshchenko, A. (3) 231-238

Deane, K.H.O., see Smith, S. (3) 261-270

Delatycki, M.B., see Mand, C.M. (3) 209-217

Deppe, M., see Reilmann, R. (1) 37-47

DiFiglia, M., see Johnson, E. (3) 219-229

DiFiglia, M., see Vodicka, P. (2) 187-201

Domínguez D, J.F., see Poudel, G.R. (4) 325-332

Dorsey, E.R., see Oster, E. (3) 271-277

Driscoll, S., see Poudel, G.R. (4) 325-332

Duff, K., see Beglinger, L.J. (3) 251-260

Duncan, R.E., see Mand, C.M. (3) 209-217

Durr, A., see Gregory, S. (3) 239-249

Durr, A., see Gregory, S. (4) 333-346

Eberly, S.W., see Oster, E. (3) 271-277

Egan, G.F., see Poudel, G.R. (4) 325-332

Elliston, L., see Mort, M. (2) 161-171

Epplen, J.T., see Arning, L. (1) 87-98

Espinoza-Huertas, K., see Cornejo-Olivas, M.R. (1) 99-105

Farmer, R.E., see Gregory, S. (4) 333-346

Fiedorowicz, J.G., see Beglinger, L.J. (3) 251-260

Flaherty, H., see Smith, S. (3) 261-270

Friedline, R.H., see Johnson, E. (3) 219-229

Frost, C., see Gregory, S. (4) 333-346

Garner, B., see Kreilaus, F. (4) 305-318

Georgiou-Karistianis, N., see Poudel, G.R. (4) 325-332

Georgiou-Karistianis, N., see Vaportzis, E. (2) 119-130

Gigengack, F., see Reilmann, R. (1) 37-47

Gillam, L., see Mand, C.M. (3) 209-217

Glajch, K.E. and G. Sadri-Vakili, Epigenetic Mechanisms Involved in Huntington’s Disease Pathogenesis (1) 1-15

Gonzalez-Alegre, P., see Tereshchenko, A. (3) 231-238

Gray, R., see Smith, S. (3) 261-270

Green, K.M., see Vodicka, P. (2) 187-201

Gregory, S., J.H. Cole, R.E. Farmer, E.M. Rees, R.A.C. Roos, R. Sprengelmeyer, A. Durr, B. Landwehrmeyer, H. Zhang, R.I. Scahill, S.J. Tabrizi, C. Frost and N.Z. Hobbs, Longitudinal Diffusion Tensor Imaging Shows Progressive Changes in White Matter in Huntington’s Disease (4) 333-346

Gregory, S., R.I. Scahill, K.K. Seunarine, C. Stopford, H. Zhang, J. Zhang, M. Orth, A. Durr, R.A.C. Roos, D.R. Langbehn, J.D. Long, H. Johnson, G. Rees, S.J. Tabrizi and D. Craufurd and the Track-HD investigators, Neuropsychiatry and White Matter Microstructure in Huntington’s Disease (3) 239-249

Guilarte, T.R., see Wegrzynowicz, M. (1) 17-36

Gusella, J.F., see Correia, K. (3) 279-284

Haider, S., see McCourt, A.C. (4) 371-382

Hannan, A.J., see Kreilaus, F. (4) 305-318

Hannan, A.J., see Renoir, T. (4) 297-303

Harold, D., see Correia, K. (3) 279-284

Harrison, D.J., see Steventon, J.J. (2) 149-160

Heidari, R., V. Monnier, E. Martin and H. Tricoire, Methylene Blue Partially Rescues Heart Defects in a Drosophila Model of Huntington’s Disease (2) 173-186

Hermann, S., see Reilmann, R. (1) 37-47

Hobbs, N.Z., see Gregory, S. (4) 333-346

Holmans, P., see Correia, K. (3) 279-284

Holt, H.K., see Wegrzynowicz, M. (1) 17-36

Hölzner, E., see Reilmann, R. (1) 37-47

Horton, M., see McNally, G. (4) 347-369

Hua, K., see Wegrzynowicz, M. (1) 17-36

Hughes, A.C., see Mort, M. (2) 161-171

Inca-Martinez, M.A., see Cornejo-Olivas, M.R. (1) 99-105

Iuliano, M., see Vodicka, P. (2) 187-201

Ivanecka, A., see Smith, S. (3) 261-270

Jacobs, A.H., see Reilmann, R. (1) 37-47

Jain, S., see Lenka, A. (4) 319-324

Jenner, A.M., see Kreilaus, F. (4) 305-318

Jetter, C.S., see Wegrzynowicz, M. (1) 17-36

Jhunjhunwala, K., see Lenka, A. (4) 319-324

Johnson, E., K. Chase, S. McGowan, E. Mondo, E. Pfister, E. Mick, R.H. Friedline, J.K. Kim, E. Sapp, M. DiFiglia and N. Aronin, Safety of Striatal Infusion of siRNA in a Transgenic Huntington’s Disease Mouse Model (3) 219-229

Johnson, H., see Gregory, S. (3) 239-249

Jones, D.K., see Steventon, J.J. (2) 149-160

Jones, L., see Correia, K. (3) 279-284

Jones, L., see Mort, M. (2) 161-171

Kamble, N.L., see Lenka, A. (4) 319-324

Kandasamy, M., see Lenka, A. (4) 319-324

Kayson-Rubin, E., see Oster, E. (3) 271-277

Kegel-Gleason, K.B., see Vodicka, P. (2) 187-201

Kim, J.K., see Johnson, E. (3) 219-229

Kim, K.-H., see Correia, K. (3) 279-284

Kreilaus, F., A.S. Spiro, A.J. Hannan, B. Garner and A.M. Jenner, Brain Cholesterol Synthesis and Metabolism is Progressively Disturbed in the R6/1 Mouse Model of Huntington’s Disease: A Targeted GC-MS/MS Sterol Analysis (4) 305-318

Kugel, H., see Reilmann, R. (1) 37-47

Kwak, S., see Correia, K. (3) 279-284

Landwehrmeyer, B., see Gregory, S. (4) 333-346

Langbehn, D., see Beglinger, L.J. (3) 251-260

Langbehn, D.R., see Gregory, S. (3) 239-249

Leavitt, B.R., see Mazarei, G. (2) 109-118

Lee, J.K., see Tereshchenko, A. (3) 231-238

Lee, J.-M., see Correia, K. (3) 279-284

Lenka, A., N.L. Kamble, V. Sowmya, K. Jhunjhunwala, R. Yadav, M. Netravathi, M. Kandasamy, N.S. Moily, M. Purushottam, S. Jain and P.K. Pal, Determinants of Onset of Huntington’s Disease with Behavioral Symptoms: Insight from 92 Patients (4) 319-324

Li, S., see Renoir, T. (4) 297-303

Lindo-Samanamud, S., see Cornejo-Olivas, M.R. (1) 99-105

Lippross, V., see Reilmann, R. (1) 37-47

Long, J.D., see Gregory, S. (3) 239-249

Loth, M.K., see Wegrzynowicz, M. (1) 17-36

Lücke, M., see Reilmann, R. (1) 37-47

MacDonald, M.E., see Correia, K. (3) 279-284

Mahdy, H.M., Huntington’s Disease in Arab Countries (3) 205-208

Mand, C.M., L. Gillam, R.E. Duncan and M.B. Delatycki, “Im scared of being like mum”: The Experience of Adolescents Living in Families with Huntington Disease (3) 209-217

Marca, V., see Cornejo-Olivas, M.R. (1) 99-105

Mariscal, N., see Cubo, E. (1) 75-85

Martin, E., see Heidari, R. (2) 173-186

Martinez, A., see Cubo, E. (1) 75-85

Mason, S. and R.A. Barker, Rating Apathy in Huntington’s Disease: Patients and Companions Agree (1) 49-59

Mazarei, G. and B.R. Leavitt, Indoleamine 2,3 Dioxygenase as a Potential Therapeutic Target in Huntington’s Disease (2) 109-118

Mazzetti, P., see Cornejo-Olivas, M.R. (1) 99-105

McCourt, A.C., J. Parker, E. Silajdžić, S. Haider, H. Sethi, S.J. Tabrizi, T.T. Warner and M. Björkqvist, Analysis of White Adipose Tissue Gene Expression Reveals CREB1 Pathway Altered in Huntington’s Disease (4) 371-382

McGlothan, J.L., see Wegrzynowicz, M. (1) 17-36

McGowan, S., see Johnson, E. (3) 219-229

McHugh, M., see Tereshchenko, A. (3) 231-238

McNally, G., H. Rickards, M. Horton and D. Craufurd, Exploring the Validity of the Short Version of the Problem Behaviours Assessment (PBA-s) for Huntington’s disease: A Rasch Analysis (4) 347-369

Mick, E., see Johnson, E. (3) 219-229

Mo, S., see Vodicka, P. (2) 187-201

Moily, N.S., see Lenka, A. (4) 319-324

Mondo, E., see Johnson, E. (3) 219-229

Monnier, V., see Heidari, R. (2) 173-186

Mora-Alferez, P., see Cornejo-Olivas, M.R. (1) 99-105

Mori, S., see Wegrzynowicz, M. (1) 17-36

Mort, M., F.A. Carlisle, A.J. Waite, L. Elliston, N.D. Allen, L. Jones and A.C. Hughes, Huntingtin Exists as Multiple Splice Forms in Human Brain (2) 161-171

Morton, A.J., see Wood, N.I. (1) 61-73

Myers, R.H., see Correia, K. (3) 279-284

Netravathi, M., see Lenka, A. (4) 319-324

Nguyen, H.P., see Reilmann, R. (1) 37-47

Nopoulos, P., see Tereshchenko, A. (3) 231-238

Oakes, D., see Oster, E. (3) 271-277

Olson, B., see Beglinger, L.J. (3) 251-260

Oosterloo, M., M.J. Van Belzen, E.K. Bijlsma and R.A.C. Roos, Is There Convincing Evidence that Intermediate Repeats in the HTT Gene Cause Huntington’s Disease? (2) 141-148

Ortega, O., see Cornejo-Olivas, M.R. (1) 99-105

Orth, M., see Correia, K. (3) 279-284

Orth, M., see Gregory, S. (3) 239-249

Osada, N., see Reilmann, R. (1) 37-47

Osmand, A.P., see Wegrzynowicz, M. (1) 17-36

Oster, E., S.W. Eberly, E.R. Dorsey, E. Kayson-Rubin, D. Oakes and I. Shoulson, Informativeness of Early Huntington Disease Signs about Gene Status (3) 271-277

Pal, P.K., see Lenka, A. (4) 319-324

Pang, T.Y., see Renoir, T. (4) 297-303

Parker, J., see McCourt, A.C. (4) 371-382

Paulsen, J.S., see Beglinger, L.J. (3) 251-260

Pfister, E., see Johnson, E. (3) 219-229

Piccini, P., see Roussakis, A.-A. (4) 287-296

Pomper, M.G., see Wegrzynowicz, M. (1) 17-36

Poudel, G.R., S. Driscoll, J.F. Domínguez D, J.C. Stout, A. Churchyard, P. Chua, G.F. Egan and N. Georgiou-Karistianis, Functional Brain Correlates of Neuropsychiatric Symptoms in Presymptomatic Huntington’s Disease: The IMAGE-HD Study (4) 325-332

Purushottam, M., see Lenka, A. (4) 319-324

Rees, E.M., see Gregory, S. (4) 333-346

Rees, G., see Gregory, S. (3) 239-249

Reilmann, R., V. Lippross, E. Hölzner, F. Gigengack, S. Bohlen, H. Kugel, M. Deppe, N. Osada, M. Lücke, O. Riess, H.P. Nguyen, S. von Hörsten, K. Schäfers, M. Schäfers, A.H. Jacobs and S. Hermann, FDG mPET Fails to Detect a Disease-Specific Phenotype in Rats Transgenic for Huntington’s Disease – A 15 Months Follow-up Study (1) 37-47

Renoir, T., T.Y. Pang, Y. Shikano, S. Li and A.J. Hannan, Loss of the Sexually Dimorphic Neuro-Inflammatory Response in a Transgenic Mouse Model of Huntington’s Disease (4) 297-303

Rickards, H., see McNally, G. (4) 347-369

Riess, O., see Reilmann, R. (1) 37-47

Rivadeneyra, J., see Cubo, E. (1) 75-85

Roos, R., see Tedroff, J. (2) 131-140

Roos, R.A.C., see Gregory, S. (3) 239-249

Roos, R.A.C., see Gregory, S. (4) 333-346

Roos, R.A.C., see Oosterloo, M. (2) 141-148

Rosser, A.E., see Steventon, J.J. (2) 149-160

Roussakis, A.-A. and P. Piccini, PET Imaging in Huntington’s Disease (4) 287-296

Sadri-Vakili, G., see Glajch, K.E. (1) 1-15

Sadri-Vakili, G., see Vodicka, P. (2) 187-201

Sapp, E., see Johnson, E. (3) 219-229

Sapp, E., see Vodicka, P. (2) 187-201

Scahill, R.I., see Gregory, S. (3) 239-249

Scahill, R.I., see Gregory, S. (4) 333-346

Schäfers, K., see Reilmann, R. (1) 37-47

Schäfers, M., see Reilmann, R. (1) 37-47

Sethi, H., see McCourt, A.C. (4) 371-382

Seunarine, K.K., see Gregory, S. (3) 239-249

Shaffer, S.A., see Vodicka, P. (2) 187-201

Shikano, Y., see Renoir, T. (4) 297-303

Shoulson, I., see Oster, E. (3) 271-277

Silajdžić, E., see McCourt, A.C. (4) 371-382

Smith, S., G. D’Cruz, R. Gray, H. Flaherty, A. Ivanecka and K.H.O. Deane, A Concept Map of What Helps People with HD Live with their Condition (3) 261-270

Soares, B.D., see Wegrzynowicz, M. (1) 17-36

Sowmya, V., see Lenka, A. (4) 319-324

Spiro, A.S., see Kreilaus, F. (4) 305-318

Sprengelmeyer, R., see Gregory, S. (4) 333-346

Squitieri, F., see Tedroff, J. (2) 131-140

Stemmler, S., see Arning, L. (1) 87-98

Steventon, J.J., D.J. Harrison, R.C. Trueman, A.E. Rosser, D.K. Jones and S.P. Brooks, In Vivo MRI Evidence that Neuropathology is Attenuated by Cognitive Enrichment in the Yac128 Huntington’s Disease Mouse Model (2) 149-160

Stopford, C., see Gregory, S. (3) 239-249

Stout, J.C., see Poudel, G.R. (4) 325-332

Stout, J.C., see Vaportzis, E. (2) 119-130

Tabrizi, S.J., see Gregory, S. (3) 239-249

Tabrizi, S.J., see Gregory, S. (4) 333-346

Tabrizi, S.J., see McCourt, A.C. (4) 371-382

Tedroff, J., S. Waters, R.A. Barker, R. Roos and F. Squitieri on behalf of the EHDN Registry Study Group, Antidopaminergic Medication is Associated with More Rapidly Progressive Huntington’s Disease (2) 131-140

Tereshchenko, A., M. McHugh, J.K. Lee, P. Gonzalez-Alegre, K. Crane, J. Dawson and P. Nopoulos, Abnormal Weight and Body Mass Index in Children with Juvenile Huntington’s Disease (3) 231-238

Tousley, A., see Vodicka, P. (2) 187-201

Tricoire, H., see Heidari, R. (2) 173-186

Trueman, R.C., see Steventon, J.J. (2) 149-160

Van Belzen, M.J., see Oosterloo, M. (2) 141-148

Vaportzis, E., N. Georgiou-Karistianis, A. Churchyard and J.C. Stout, Dual Task Performance May be a Better Measure of Cognitive Processing in Huntington’s Disease than Traditional Attention Tests (2) 119-130

Velit-Salazar, M.R., see Cornejo-Olivas, M.R. (1) 99-105

Veliz-Otani, D., see Cornejo-Olivas, M.R. (1) 99-105

Vodicka, P., S. Mo, A. Tousley, K.M. Green, E. Sapp, M. Iuliano, G. Sadri-Vakili, S.A. Shaffer, N. Aronin, M. DiFiglia and K.B. Kegel-Gleason, Mass Spectrometry Analysis of Wild-Type and Knock-in Q140/Q140 Huntington’s Disease Mouse Brains Reveals Changes in Glycerophospholipids Including Alterations in Phosphatidic Acid and Lyso-Phosphatidic Acid (2) 187-201

von Hörsten, S., see Reilmann, R. (1) 37-47

Waite, A.J., see Mort, M. (2) 161-171

Warner, T.T., see McCourt, A.C. (4) 371-382

Waters, S., see Tedroff, J. (2) 131-140

Wegrzynowicz, M., T.J. Bichell, B.D. Soares, M.K. Loth, J.L. McGlothan, F.S. Alikhan, K. Hua, J.M. Coughlin, H.K. Holt, C.S. Jetter, S. Mori, M.G. Pomper, A.P. Osmand, T.R. Guilarte and A.B. Bowman, Novel BAC Mouse Model of Huntington’s Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype (1) 17-36

Wheeler, V.C., see Correia, K. (3) 279-284

Witt, C.N., see Arning, L. (1) 87-98

Wood, N.I. and A.J. Morton, Social Behaviour is Impaired in the R6/2 Mouse Model of Huntington’s Disease (1) 61-73

Yadav, R., see Lenka, A. (4) 319-324

Zhang, H., see Gregory, S. (3) 239-249

Zhang, H., see Gregory, S. (4) 333-346

Zhang, J., see Gregory, S. (3) 239-249